NLRP3 and obesity due to melanocortin 4 receptor deficiency: We hypothesized that colchicine could have a great impact on obesity and MS due to its anti-inflammatory effects, especially in the NLRP3 inflammasome, a key component of chronic inflammation in obese patients [20,21].